SCHEMBL23947875

SCHEMBL23947875

c1ccc(-c2nc(-c3ccc4c(c3)oc3cccc(-c5cccc6c5c5ccccc5n6-c5ccccc5)c34)nc(-c3ccc4oc5ccccc5c4c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
CHEK2 O96017 1/20 0.34
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MMP12 P39900 1/20 0.33
PTGER4 P35408 1/20 0.32
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PLA2G10 O15496 1/20 0.31
PLA2G2A P14555 1/20 0.31
PLA2G4A P47712 1/20 0.31
PRKDC P78527 1/20 0.31
AHR P35869 2/20 0.30
MAPT P10636 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23947903 0.97 KDM4E (0.34) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL21192255 0.97 KDM4E (0.35) SIRT2SIRT1KDM4EATML3MBTL1
SCHEMBL21192087 0.96 KDM4E (0.35) SIRT2SIRT1KDM4EATML3MBTL1
SCHEMBL23947290 0.95 SIRT2 (0.33) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL24264168 0.95 SIRT2 (0.33) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL23947362 0.95 SIRT2 (0.33) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL26194198 0.95 SIRT2 (0.34) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL23947909 0.95 SIRT2 (0.35) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL23947904 0.95 SIRT2 (0.35) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1
SCHEMBL23947881 0.95 SIRT2 (0.35) SIRT2SIRT1CHEK2HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 SIRT2 924/4885SIRT1 1253/4885CHEK2 1929/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 SIRT2 875/4885SIRT1 1239/4885CHEK2 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.